Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.54 |
| ▸ | APAF1 | O14727 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8020779 | 1.00 | SLC22A1 (0.62) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL8026840 | 1.00 | SLC22A1 (0.62) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Water SCHEMBL590034 | 0.82 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL4596200 | 0.81 | APAF1 (0.52) | SLC22A1SMN1; SMN2DNM1APAF1HSP90AA1 | |
| SCHEMBL5884703 | 0.81 | APAF1 (0.52) | SLC22A1SMN1; SMN2DNM1APAF1HSP90AA1 | |
| Tetrahexylammonium SCHEMBL28553561 | 0.80 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL28552746 | 0.80 | ALDH1A1 (0.74) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL11425180 | 0.80 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL10909488 | 0.80 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL11425178 | 0.80 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1005447-B1 | METHOD FOR PRODUCING LONG-CHAIN GLYCINE-N,N-DIACETIC ACID DERIVATIVES | BASF AG (DE) | 2003-04-23 | — | — | EP | disclosed |
| US-6420593-B2 | COMPRISES REACTING IMINODIACETONITRILE WITH ALDEHYDES AND HYDROGEN CYANIDE OR ALKALI METAL CYANIDES; USEFUL AS BIODEGRADABLE COMPLEXING AGENTS FOR ALKALI METAL AND HEAVY METAL IONS | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-16 | — | — | US | disclosed |
| US-20010034457-A1 | Method for producing long-chain glycine-N,N-diacetic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-25 | — | — | US | disclosed |
| US-6307086-B1 | PREPARATION OF LONG-CHAIN SUBSTITUTED NITRILOTRIACETONITRILES FROM IMINODIACETONITRILE, LONG-CHAIN ALDEHYDE AND HCN OR ALKALI METAL CYANIDE OR FROM AN ALPHA-AMINO LONG-CHAIN NITRILE, FORMALDEHYDE AND HCN OR ALKALI METAL CYANIDE | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-23 | — | — | US | disclosed |
| EP-1005447-A2 | METHOD FOR PRODUCING LONG-CHAIN GLYCINE-N,N-DIACETIC ACID DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-07 | — | — | EP | disclosed |
| WO-1999010314-A2 | METHOD FOR PRODUCING LONG-CHAIN GLYCINE-N,N-DIACETIC ACID DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1999-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010034457-A1 | Method for producing long-chain glycine-N,N-diacetic acid derivatives | SCO2, HAO2, CLIC1 | SLC22A1 626/4885ALDH1A1 791/4885TP53 3976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.